Phasic ion channel blockade. A kinetic model and parameter estimation procedure

CF Starmer and AO Grant

For excitable membranes, use and frequency dependence represent a progressive incorporation of drug into gated ion channels with repetitive stimulation. In contrast to receptors where access to ligand is continuous in time, we define guarded receptors, such as gated ion channels, as receptors whose access to the ligand pool is transient and controlled by the channel-gating process. During repetitive stimulation, the fraction of ligand-bound channels (ion channel blockade) follows an exponential time course, determined by the interstimulus interval, channel-gating processes, drug concentration, and the forward and reverse rate coefficients characteristic of the binding process. Based on a first order model of ligand-receptor binding, we derive a characterization of ion channel blockade via a single diffusion path under conditions of repetitive phasic stimulation. Extension to multiple diffusion paths and multiple drugs leads to a more complex scheme, but these generalizations are straightforward. For the case of one diffusion path, we derive the steady state level of channel blockade for guarded receptors as a function of stimulus rate and develop a data analysis strategy suitable for characterizing ion channel-blocking agents such as local anesthetics and antiarrhythmic drugs. We show that as receptor access time increases, the transient and steady state properties of guarded receptors become equivalent to those derived from the standard continuous access ligand-receptor model. The analysis tools presented simplify the quantitative description of the functional properties of many ion channel blockers and appear to have general applicability to characterization of periodically accessible receptors.

Volume 28, Issue 4, pp. 348-356, 10/01/1985
Copyright © 1985 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				Y. Zhu, J. W. Kyle, and P. J. Lee Flecainide sensitivity of a Na channel long QT mutation shows an open-channel blocking mechanism for use-dependent block Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H29 - H37. [Abstract] [Full Text] [PDF]

				A. Omelchenko, R. Bouchard, S. Shurraw, M. Trac, M. Hnatowich, and L. V. Hryshko Frequency-dependent regulation of cardiac Na+/Ca2+ exchanger Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1594 - H1603. [Abstract] [Full Text] [PDF]

				C.F. Starmer, A.O. Grant, and T.J. Colatsky What happens when cardiac Na channel function is compromised? 2. Numerical studies of the vulnerable period in tissue altered by drugs Cardiovasc Res, March 15, 2003; 57(4): 1062 - 1071. [Abstract] [Full Text] [PDF]

				S. Berjukow, F. Gapp, S. Aczel, M. J. Sinnegger, J. Mitterdorfer, H. Glossmann, and S. Hering Sequence Differences between alpha 1C and alpha 1S Ca2+ Channel Subunits Reveal Structural Determinants of a Guarded and Modulated Benzothiazepine Receptor J. Biol. Chem., March 5, 1999; 274(10): 6154 - 6160. [Abstract] [Full Text] [PDF]

				S. Hering, S. Aczel, R. L. Kraus, S. Berjukow, J. Striessnig, and E. N. Timin Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: Role of inactivation PNAS, November 25, 1997; 94(24): 13323 - 13328. [Abstract] [Full Text] [PDF]

				S. Hering, S. Aczel, M. Grabner, F. Doring, S. Berjukow, J. Mitterdorfer, M. J. Sinnegger, J. Striessnig, V. E. Degtiar, Z. Wang, et al. Transfer of High Sensitivity for Benzothiazepines from L-type to Class A (BI) Calcium Channels J. Biol. Chem., October 4, 1996; 271(40): 24471 - 24475. [Abstract] [Full Text] [PDF]

				C. Valenzuela, D. J. Snyders, P. B. Bennett, J. Tamargo, and L. M. Hondeghem Stereoselective Block of Cardiac Sodium Channels by Bupivacaine in Guinea Pig Ventricular Myocytes Circulation, November 15, 1995; 92(10): 3014 - 3024. [Abstract] [Full Text]

				P. B. Bennett, C. Valenzuela, L.-Q. Chen, and R. G. Kallen On the Molecular Nature of the Lidocaine Receptor of Cardiac Na+ Channels : Modification of Block by Alterations in the {alpha}-Subunit III-IV Interdomain Circ. Res., September 1, 1995; 77(3): 584 - 592. [Abstract] [Full Text]

				P. J. Lee, A. Sunami, and H. A. Fozzard Cardiac-Specific External Paths for Lidocaine, Defined by Isoform-Specific Residues, Accelerate Recovery From Use-Dependent Block Circ. Res., November 23, 2001; 89(11): 1014 - 1021. [Abstract] [Full Text] [PDF]